Greg Guyer
About Greg Guyer
Greg Guyer is the Global Head of Operations at Bristol-Myers Squibb in New Jersey, United States, with extensive experience in biologics operations, quality assurance, and global manufacturing strategies.
Current Position at Bristol-Myers Squibb
Greg Guyer currently serves as the Global Head of Operations at Bristol-Myers Squibb in New Jersey, United States. His role encompasses overseeing the company's global operations, with a focus on maximizing operational efficiency and managing a vast network of manufacturing and packaging sites. His leadership is integral to ensuring the seamless delivery of key brands across global markets.
Previous Roles at Bristol-Myers Squibb
Before his current role, Greg Guyer was the Global Head and Senior Vice President of Biologics Operations and Process Development at Bristol-Myers Squibb from 2015 to 2017. During his tenure, he directed the optimization of biologic processes, which resulted in significant cost savings and enhanced commercial production capabilities. Guyer’s leadership in biologics was critical in improving both process development and operational efficiency.
Career at Merck
Guyer held several key positions at Merck from 1994 to 2015, including Senior Vice President of Operations, Biologics, Therapeutic Proteins and Sterile Products, and Vice President roles across emerging markets, quality operations, and global quality. His extensive experience at Merck involved managing a global network strategy transformation, achieving a 99.5% customer service level, and overseeing an annual budget exceeding $1.5 billion. He also delivered total savings of $450 million over five years by externalizing inline small molecules.
Education and Academic Background
Greg Guyer holds a Doctor of Philosophy in Philosophy and Chemistry from American University, earned between 1986 and 1991. He also has a Master of Business Administration in Marketing from Lehigh University, which he completed between 1995 and 1998. Additionally, he achieved a Bachelor of Science in Chemistry from The University of Georgia, Franklin College of Arts and Sciences, completed between 1979 and 1983.
Contributions and Impact
Throughout his career, Greg Guyer has made significant contributions to the pharmaceutical industry. He led over 4000 employees, optimized biologic launches and commercial production, and oversaw substantial cost-saving initiatives. Notably, during his leadership, he managed to achieve a 99.5% customer service level globally and delivered $450 million in savings by externalizing production processes.